Close Menu

NEW YORK (GenomeWeb) – Roche announced today that it has received approval from the US Food and Drug Administration for its Cobas MPX test, a nucleic acid test for the detection of HIV, hepatitis B, and hepatitis C in human blood plasma and serum.

The assay, which is approved for use on the company's Cobas 6800 and 8800 systems, allows screening labs in the US to use advanced PCR-based diagnostic technology to screen donated blood and plasma, to prevent the spread of HIV-1 and HIV-2, HBV, and HCV through transfused blood products.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
24
Sponsored by
Hologic

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul
25
Sponsored by
Roche

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.